Tranexamic Acid
NDC 69918-301, Tranexamic Acid, tablet, from Nordic Pharma, Inc..
- Product NDC
- 69918-301
- Status
- Listed
- Labeler
- Nordic Pharma, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA022430
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69918-301 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TRANEXAMIC ACID650 mg/1
Pharmacologic classes
Antifibrinolytic Agent [EPC]; Decreased Fibrinolysis [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69918-301-30 | 69918030130 | 30 TABLET in 1 BOTTLE (69918-301-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/031bf7c2-3b07-469d-bc5a-31fc6238e25fNADAC price for package 69918030130
GET /v1/drugs/nadac/69918030130
Use it
Look up 69918-301 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69918-301 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69918-301. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.